Cargando…
1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
BACKGROUND: In critically ill patients, rectal colonization with VRE is associated with an increased risk for nosocomial infection or death. In mice, fecal transplantation of Blautia producta directly inhibits VRE growth and leads to clearance of VRE. We performed a prospective, intensive care unit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252724/ http://dx.doi.org/10.1093/ofid/ofy209.157 |
_version_ | 1783373329776771072 |
---|---|
author | Cuaresma, Edward Laszkowska, Monica Stump, Stephania Moscoso, Dagmara Chong, David Freedberg, Daniel |
author_facet | Cuaresma, Edward Laszkowska, Monica Stump, Stephania Moscoso, Dagmara Chong, David Freedberg, Daniel |
author_sort | Cuaresma, Edward |
collection | PubMed |
description | BACKGROUND: In critically ill patients, rectal colonization with VRE is associated with an increased risk for nosocomial infection or death. In mice, fecal transplantation of Blautia producta directly inhibits VRE growth and leads to clearance of VRE. We performed a prospective, intensive care unit (ICU)-based study to evaluate the relationship between B. producta and VRE. We also sought to determine the relationship between VRE, MRSA, and other common MDR bacteria. METHODS: This study included 97 adults newly admitted to the ICU between February 2015 and June 2016. Rectal swabs were obtained at time of ICU admission and 72 hours later. VRE rectal colonization status was determined categorically for each sample by culture on selective media. Specimens were also cultured for methicillin-resistant Staphylococcus aureus (MRSA) and for MDR Gram-negatives, defined as those with nonsusceptibility to 3 or more antibiotic classes. 16S rRNA gene sequencing was performed and the relative abundance was calculated for B. producta. Differentially abundant bacteria taxa between VRE positive and VRE negative specimens were assessed using linear discriminant analysis effect size (LefSe) analysis. RESULTS: Among the 97 patients, 7 (7.2%) were colonized with VRE at the time of ICU admission and 3 (3.3%) of the remaining patients became colonized 72 hours later. The microbiome composition differed significantly when accounting for VRE colonization status. The relative abundance of B. producta was 140-fold higher in VRE-negative compared with VRE-positive samples (0.0012% vs. 8.48 × 10(–6)%, P = 0.03). On LefSe analysis, there was also significantly lower differential abundance of B. producta when VRE was present (LDA score 4.65). The presence of VRE in culture was significantly associated with the co-presence of MRSA (23.5% co-colonized if VRE positive vs. 8.4% if VRE negative, P = 0.046) but not with the copresence of MDR Gram-negative bacteria (29.4% if cocolonized if VRE positive vs. 34.3% if VRE negative, P = 0.68). CONCLUSION: In this ICU cohort, rectal colonization with VRE was inversely associated with the putatively protective organism B. producta. VRE was associated with rectal co-colonization with MRSA but not with MDR Gram-negative bacteria. B. producta may have promise as a probiotic designed to prevent VRE colonization. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6252724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62527242018-11-28 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients Cuaresma, Edward Laszkowska, Monica Stump, Stephania Moscoso, Dagmara Chong, David Freedberg, Daniel Open Forum Infect Dis Abstracts BACKGROUND: In critically ill patients, rectal colonization with VRE is associated with an increased risk for nosocomial infection or death. In mice, fecal transplantation of Blautia producta directly inhibits VRE growth and leads to clearance of VRE. We performed a prospective, intensive care unit (ICU)-based study to evaluate the relationship between B. producta and VRE. We also sought to determine the relationship between VRE, MRSA, and other common MDR bacteria. METHODS: This study included 97 adults newly admitted to the ICU between February 2015 and June 2016. Rectal swabs were obtained at time of ICU admission and 72 hours later. VRE rectal colonization status was determined categorically for each sample by culture on selective media. Specimens were also cultured for methicillin-resistant Staphylococcus aureus (MRSA) and for MDR Gram-negatives, defined as those with nonsusceptibility to 3 or more antibiotic classes. 16S rRNA gene sequencing was performed and the relative abundance was calculated for B. producta. Differentially abundant bacteria taxa between VRE positive and VRE negative specimens were assessed using linear discriminant analysis effect size (LefSe) analysis. RESULTS: Among the 97 patients, 7 (7.2%) were colonized with VRE at the time of ICU admission and 3 (3.3%) of the remaining patients became colonized 72 hours later. The microbiome composition differed significantly when accounting for VRE colonization status. The relative abundance of B. producta was 140-fold higher in VRE-negative compared with VRE-positive samples (0.0012% vs. 8.48 × 10(–6)%, P = 0.03). On LefSe analysis, there was also significantly lower differential abundance of B. producta when VRE was present (LDA score 4.65). The presence of VRE in culture was significantly associated with the co-presence of MRSA (23.5% co-colonized if VRE positive vs. 8.4% if VRE negative, P = 0.046) but not with the copresence of MDR Gram-negative bacteria (29.4% if cocolonized if VRE positive vs. 34.3% if VRE negative, P = 0.68). CONCLUSION: In this ICU cohort, rectal colonization with VRE was inversely associated with the putatively protective organism B. producta. VRE was associated with rectal co-colonization with MRSA but not with MDR Gram-negative bacteria. B. producta may have promise as a probiotic designed to prevent VRE colonization. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252724/ http://dx.doi.org/10.1093/ofid/ofy209.157 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Cuaresma, Edward Laszkowska, Monica Stump, Stephania Moscoso, Dagmara Chong, David Freedberg, Daniel 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title | 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title_full | 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title_fullStr | 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title_full_unstemmed | 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title_short | 1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients |
title_sort | 1772. vancomycin-resistant enterococcus alters the gastrointestinal microbiome in critically ill patients |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252724/ http://dx.doi.org/10.1093/ofid/ofy209.157 |
work_keys_str_mv | AT cuaresmaedward 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients AT laszkowskamonica 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients AT stumpstephania 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients AT moscosodagmara 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients AT chongdavid 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients AT freedbergdaniel 1772vancomycinresistantenterococcusaltersthegastrointestinalmicrobiomeincriticallyillpatients |